How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura? [9]

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 433-

  Benesch, Martin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE;

CHILD CARE; CHRONIC DISEASE; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; COST UTILITY ANALYSIS; DRUG COST; DRUG DOSE COMPARISON; DRUG INDICATION; DRUG MEGADOSE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; LOW DRUG DOSE; MEDICAL DECISION MAKING; OUTPATIENT; PRIORITY JOURNAL; RISK REDUCTION; SINGLE DRUG DOSE; TREATMENT OUTCOME;

CHILD; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG COSTS; DRUG THERAPY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; METHYLPREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 37549047217     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21231     Document Type: Letter

References (7)

1. O'Brien SH, Richey AK, Smith KJ. A cost-utility analysis of treatment for childhood acute idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2007;48:173-180.
2. Benesch M, Kerbl R, Lackner H, et al. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: Results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol 2003;25:797-800.
3. Warrier I, Bussel JB, Valdez L, et al. Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 1997;19:197-201.
4. Bruin M, Bierings M, Uiterwald C, et al. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: Results of a prospective study. Br J Haematol 2004;127:561-567.
5. Beck CE, Nathan PC, Parkin PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute idiopathic thrombocytopenic purpura in children: A systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005;147:521-527.
6. Dickerhoff R, von Rücker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000;137:629-632.
7. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002;141:683-688.